Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Feb. 29, 2020
Feb. 28, 2019
Operating activities    
Net income $ 877.4 $ 804.0
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization on property and equipment and intangible assets 158.0 125.7
Amortization of premiums and discounts on available-for-sale securities, net 30.7 38.8
Amortization of deferred contract costs 139.1 134.8
Stock-based compensation costs 36.5 33.6
(Benefit)/provision for deferred income taxes (7.7) 10.7
Provision for allowance for doubtful accounts 6.0 2.1
Net realized (gains)/losses on sales of available-for-sale securities (2.4) 0.1
Changes in operating assets and liabilities:    
Interest receivable 1.3 8.5
Accounts receivable and PEO unbilled receivables, net 0.1 (110.2)
Prepaid expenses and other current assets (15.6) 8.4
Accounts payable and other current liabilities (26.5) 108.4
Deferred costs (141.4) (134.1)
Net change in other long-term assets and liabilities (2.3) (8.0)
Net change in operating lease right-of-use assets and liabilities (0.5)
Net cash provided by operating activities 1,052.7 1,022.8
Investing activities    
Purchases of available-for-sale securities (21,852.6) (26,247.6)
Proceeds from sales and maturities of available-for-sale securities 22,323.4 26,784.6
Purchases of property and equipment (91.9) (88.0)
Acquisition of businesses, net of cash acquired (6.3) (984.1)
Purchases of other assets (8.2) (3.5)
Net cash provided by/(used in) investing activities 364.4 (538.6)
Financing activities    
Net change in client fund obligations 487.7 680.5
Net proceeds from short-term borrowings 51.2 53.6
Proceeds from borrowings to fund acquisition 800.0
Dividends paid (666.8) (603.9)
Repurchases of common shares (171.9) (32.8)
Activity related to equity-based plans 20.0 23.4
Net cash (used in)/provided by financing activities (279.8) 920.8
Net change in cash, cash equivalents, restricted cash and restricted cash equivalents 1,137.3 1,405.0
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period 935.2 2,300.5
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period 2,072.5 3,705.5
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents to the Consolidated Balance Sheets:    
Cash and cash equivalents 780.0 696.4
Restricted cash 66.4 134.4
Restricted cash and restricted cash equivalents included in funds held for clients $ 1,226.1 $ 2,874.7